Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 02-Oct-24 2:01 PM View:  | Hu Ben Director | Nexalin Technology, Inc. (NXL) | 30-Sep-24 | Grant | 175,000 | -- | -- | 106% 165.64K to 340.64K | |
| 02-Oct-24 2:02 PM View: | Bernhard Leslie Director | Nexalin Technology, Inc. (NXL) | 30-Sep-24 | Grant | 49,838 | -- | -- | 100% 0 to 49.84K | |
| 25-Sep-24 5:27 PM View: | Elson Marilyn 10% Owner | Nexalin Technology, Inc. (NXL) | 23-Sep-24 | Grant | 700,000 | -- | -- | 84% 835.24K to 1.54M | |
| 15-Aug-24 4:25 PM View: | Owens David Chief Medical Officer Director | Nexalin Technology, Inc. (NXL) | 13-Aug-24 | Private Purchase | 1,000 | $0.95 | $950.00 | < 1% 146.79K to 147.79K | |
| 01-Jul-24 1:47 PM View: | Owens David Chief Medical Officer Director | Nexalin Technology, Inc. (NXL) | 28-Jun-24 | Purchase | 1,000 | $1.75 | $1,750.00 | < 1% 145.79K to 146.79K | |
| 21-Jun-24 11:21 AM View: | Owens David Chief Medical Officer Director | Nexalin Technology, Inc. (NXL) | 18-Jun-24 | Private Purchase | 1,619 | $0.71 | $1,149.49 | 1% 144.17K to 145.79K | |
| 12-Jun-24 1:19 PM View: | Owens David Chief Medical Officer Director | Nexalin Technology, Inc. (NXL) | 10-Jun-24 | Private Purchase | 3,000 | $0.64 | $1,920.00 | 2% 141.17K to 144.17K | |
| 29-Sep-22 12:30 PM View: | Elson Marilyn 10% Owner | Nexalin Technology, Inc. (NXL) | 28-Sep-22 | Private Purchase | 9,500 | $1.12 | $10,640.00 | 1% 825.74K to 835.24K | |
| 20-Sep-22 2:24 PM View: | Morad Rick Director | Nexalin Technology, Inc. (NXL) | 16-Sep-22 | Purchase | 2,500 | $4.15 | $10,375.00 | 1% 167.27K to 169.77K | |
| 20-Sep-22 2:29 PM View: | Elson Marilyn Ms. Elson serves as CFO 10% Owner | Nexalin Technology, Inc. (NXL) | 16-Sep-22 | Purchase | 36,000 | $4.15 | $149,400.00 | 5% 789.74K to 825.74K | |
| 20-Sep-22 2:05 PM View: | White Mark President/CEO Director | Nexalin Technology, Inc. (NXL) | 16-Sep-22 | Purchase | 2,500 | $4.15 | $10,375.00 | < 1% 287.13K to 289.63K | |
| 20-Sep-22 2:06 PM View: | Kazden Alan Director | Nexalin Technology, Inc. (NXL) | 16-Sep-22 | Purchase Duplicate | 2,500 | $4.15 | $10,375.00 | 3% 86.63K to 89.13K | |
| 20-Sep-22 2:05 PM View: | Owens David Chief Medical Officer Director | Nexalin Technology, Inc. (NXL) | 16-Sep-22 | Purchase | 2,500 | $4.15 | $10,375.00 | 2% 138.67K to 141.17K |
